CNBX
CNBX Pharmaceuticals Inc.
$0.00
+0.00 (+0.00%)
At close · Jul 3
Going-concern doubt
— flagged Jun 24, 2026
Substantial doubt about the company's ability to continue as a going concern.
“While the Company has incurred a net loss of $311,982 for the nine months ended May 31, 2026, it has incurred cumulative losses since inception of $25,580,358. These conditions raise substantial doubt about the ability of the Company to continue as a going concern.”View the 10-Q filed Jun 24, 2026
Market Cap
$240,865
Shares
1,605,768,095
Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.
Holders: 2
Total Value: $25,252
Total Shares: 3,412,566
Institutional Ownership Trend
10 quarters
Quarterly Activity
vs Sep 30, 2024
New
1
Increased
0
Decreased
0
Sold Out
0
Unchanged
1
Holder count:
+1
Institutional value:
—
Shares held:
+37917300.0%
Top New Positions
vs Sep 30, 2024| Institution | Acquired | Value (USD) | Open |
|---|---|---|---|
| — 3i, LP | 3,412,557 | $25,252 |
Top Sold-Out Positions
vs Sep 30, 2024No fully closed positions this quarter.
| Holder | Value (USD) | % of 13F | Shares | Type | Discretion | Filed | Open | |||
|---|---|---|---|---|---|---|---|---|---|---|
| — 3i, LP | $25,252 | 100.00% | 3,412,557 | Shares | Sole | 2025-02-13 | ||||
| Small Archer Investment Corp | $0 | 0.00% | 9 | Shares | Sole | 2025-01-28 | ||||
| No holders match your search. | ||||||||||